制定和更新基于指南的肺癌质量指标。

IF 1.2 Q4 RESPIRATORY SYSTEM
Pneumologie Pub Date : 2024-04-01 Epub Date: 2023-12-11 DOI:10.1055/a-2204-4879
Martin Utzig, Hans Hoffmann, Niels Reinmuth, Wolfgang Schütte, Thomas Langer, Jessica Lobitz, Johannes Rückher, Simone Wesselmann
{"title":"制定和更新基于指南的肺癌质量指标。","authors":"Martin Utzig, Hans Hoffmann, Niels Reinmuth, Wolfgang Schütte, Thomas Langer, Jessica Lobitz, Johannes Rückher, Simone Wesselmann","doi":"10.1055/a-2204-4879","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In 2022, an update of the German lung cancer guideline, first published in 2010 and revised in 2018, was released. This article aims to show the process of updating, developing, and implementing guideline-based quality indicators (QI) into the certification system for lung cancer centers (LCC).</p><p><strong>Methods: </strong>A multidisciplinary and interprofessional working group revised the guideline QIs from 2018 using the strong recommendations of the guideline update, a systematic review for QIs, and the results of the implemented QIs from LCC.</p><p><strong>Results: </strong>For 4 out of 8 indicators from the 2018 guideline, the LCC showed an improved implementation of the requirements in the last 3 years (2018-2020). For 3 indicators, the median of the results was constant at a very high level (≥96% or 100%). Only the \"adjuvant cisplatin-based chemotherapy\" indicator showed declining values between 2018 and 2020. The target values and plausibility limits were well achieved by LCC. After updating the guideline, one QI from 2018 was not included in the new QI set due to the small denominator population. Based on the new strong recommendations, 8 new QIs were defined. From the QI set of the guideline update, 13 of 15 indicators (7 since 2018 and 6 from 2022 on) were adopted into the certification program.</p><p><strong>Conclusions: </strong>The guideline recommendations are implemented by LCC at a high level. The process presented confirms the successful implementation of the so-called quality cycle in oncology. The QIs developed by the German Guideline Program in Oncology (GGPO) are adopted by the certification program. The implementation of the QI is measured in LCC, evaluated by the German Cancer Society (DKG), and reflected back to the GGPO. The \"real world\" data have led to the deletion of one QI and show a high implementation of most QIs in LCC.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development and Update of Guideline-based Quality Indicators in Lung Cancer.\",\"authors\":\"Martin Utzig, Hans Hoffmann, Niels Reinmuth, Wolfgang Schütte, Thomas Langer, Jessica Lobitz, Johannes Rückher, Simone Wesselmann\",\"doi\":\"10.1055/a-2204-4879\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>In 2022, an update of the German lung cancer guideline, first published in 2010 and revised in 2018, was released. This article aims to show the process of updating, developing, and implementing guideline-based quality indicators (QI) into the certification system for lung cancer centers (LCC).</p><p><strong>Methods: </strong>A multidisciplinary and interprofessional working group revised the guideline QIs from 2018 using the strong recommendations of the guideline update, a systematic review for QIs, and the results of the implemented QIs from LCC.</p><p><strong>Results: </strong>For 4 out of 8 indicators from the 2018 guideline, the LCC showed an improved implementation of the requirements in the last 3 years (2018-2020). For 3 indicators, the median of the results was constant at a very high level (≥96% or 100%). Only the \\\"adjuvant cisplatin-based chemotherapy\\\" indicator showed declining values between 2018 and 2020. The target values and plausibility limits were well achieved by LCC. After updating the guideline, one QI from 2018 was not included in the new QI set due to the small denominator population. Based on the new strong recommendations, 8 new QIs were defined. From the QI set of the guideline update, 13 of 15 indicators (7 since 2018 and 6 from 2022 on) were adopted into the certification program.</p><p><strong>Conclusions: </strong>The guideline recommendations are implemented by LCC at a high level. The process presented confirms the successful implementation of the so-called quality cycle in oncology. The QIs developed by the German Guideline Program in Oncology (GGPO) are adopted by the certification program. The implementation of the QI is measured in LCC, evaluated by the German Cancer Society (DKG), and reflected back to the GGPO. The \\\"real world\\\" data have led to the deletion of one QI and show a high implementation of most QIs in LCC.</p>\",\"PeriodicalId\":20197,\"journal\":{\"name\":\"Pneumologie\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pneumologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2204-4879\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/12/11 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pneumologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-2204-4879","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/11 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

摘要

背景:2022年,德国肺癌指南更新版发布,该指南于2010年首次发布,并于2018年进行了修订。本文旨在展示基于指南的质量指标(QI)的更新、制定和实施过程,并将其纳入肺癌中心(LCC)的认证体系:一个多学科和跨专业工作组利用指南更新中的有力建议、对质量指标的系统回顾以及 LCC 实施质量指标的结果,修订了 2018 年的指南质量指标:在 2018 年指南的 8 项指标中,有 4 项指标的 LCC 显示,在过去 3 年(2018-2020 年)中,这些要求的实施情况有所改善。对于 3 项指标,结果的中位数始终保持在很高的水平(≥96% 或 100%)。只有 "以顺铂为基础的辅助化疗 "指标的数值在2018年至2020年期间有所下降。LCC很好地实现了目标值和可信限值。更新指南后,由于分母人群较小,2018 年的一项 QI 未纳入新的 QI 集。根据新的强烈建议,定义了 8 个新的 QI。在指南更新后的质量指标集中,15 个指标中有 13 个(7 个自 2018 年起,6 个自 2022 年起)被采用到认证计划中:LCC 高水平地实施了指南建议。所介绍的过程证实了所谓的肿瘤学质量周期的成功实施。德国肿瘤学指南项目(GGPO)制定的 QI 被认证项目采纳。QI 的实施情况在 LCC 中进行测量,由德国癌症协会 (DKG) 进行评估,并反馈给 GGPO。现实世界 "的数据导致删除了一项 QI,并表明大多数 QI 在 LCC 中的实施率很高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Development and Update of Guideline-based Quality Indicators in Lung Cancer.

Background: In 2022, an update of the German lung cancer guideline, first published in 2010 and revised in 2018, was released. This article aims to show the process of updating, developing, and implementing guideline-based quality indicators (QI) into the certification system for lung cancer centers (LCC).

Methods: A multidisciplinary and interprofessional working group revised the guideline QIs from 2018 using the strong recommendations of the guideline update, a systematic review for QIs, and the results of the implemented QIs from LCC.

Results: For 4 out of 8 indicators from the 2018 guideline, the LCC showed an improved implementation of the requirements in the last 3 years (2018-2020). For 3 indicators, the median of the results was constant at a very high level (≥96% or 100%). Only the "adjuvant cisplatin-based chemotherapy" indicator showed declining values between 2018 and 2020. The target values and plausibility limits were well achieved by LCC. After updating the guideline, one QI from 2018 was not included in the new QI set due to the small denominator population. Based on the new strong recommendations, 8 new QIs were defined. From the QI set of the guideline update, 13 of 15 indicators (7 since 2018 and 6 from 2022 on) were adopted into the certification program.

Conclusions: The guideline recommendations are implemented by LCC at a high level. The process presented confirms the successful implementation of the so-called quality cycle in oncology. The QIs developed by the German Guideline Program in Oncology (GGPO) are adopted by the certification program. The implementation of the QI is measured in LCC, evaluated by the German Cancer Society (DKG), and reflected back to the GGPO. The "real world" data have led to the deletion of one QI and show a high implementation of most QIs in LCC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pneumologie
Pneumologie RESPIRATORY SYSTEM-
CiteScore
1.80
自引率
16.70%
发文量
416
期刊介绍: Organ der Deutschen Gesellschaft für Pneumologie DGP Organ des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose DZK Organ des Bundesverbandes der Pneumologen BdP Fachärzte für Lungen- und Bronchialheilkunde, Pneumologen und Allergologen
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信